Raymond James & Associates’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

Raymond James & Associates’s Portfolio KYTH Stock Details KYTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-40,178	Closed	-$3.01M	–	2458
2015 Q3	$3.01M	Sell	40,178 -2,223	-5%	-$166K	0.01%	1000
2015 Q2	$3.19M	Buy	42,401 +702	+2%	+$37.6K	0.01%	1057
2015 Q1	$2.09M	Sell	41,699 -480	-1%	-$20.1K	0.01%	1214
2014 Q4	$1.46M	Buy	42,179 +358	+0.9%	+$12.5K	0.01%	1330
2014 Q3	$1.37M	Buy	41,821 +3,167	+8%	+$112K	0.01%	1313
2014 Q2	$1.48M	Buy	38,654 +14,361	+59%	+$501K	0.01%	1261
2014 Q1	$966K	Buy	24,293 +882	+4%	+$39.5K	0.01%	1443
2013 Q4	$874K	Buy	+23,411	New	+$971K	0.01%	1396

Raymond James & Associates's KYTH Position: Q4 2015 in Review

Raymond James & Associates sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q4 2015, closing a stake of 40,178 shares — an estimated $3.01M sold.

Raymond James & Associates first reported a position in KYTH in Q4 2013 and held it in 8 quarters. The position peaked at $3.19M in Q2 2015. 0 funds tracked by Wall St. Rank hold KYTH as of Q4 2015.

Raymond James & Associates reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q4 2015 after selling out during the quarter.
Raymond James & Associates sold 40,178 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q4 2015, an estimated $3.01M.
Raymond James & Associates first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q4 2013 and held it in 8 quarters.
Raymond James & Associates's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $3.19M in Q2 2015.
0 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q4 2015.

Based on Raymond James & Associates's 13F filing for Q4 2015, filed 16 Feb 2016.